Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aagenaes O., TFagerhol M., Elgjo K., Munthe E., Hovig T. Pathology and pathogenesis of liver disease in alpha-1-antitrypsin deficient individuals. Postgrad Med J. 1974 Jun;50(584):365–375. doi: 10.1136/pgmj.50.584.365. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Berg N. O., Eriksson S. Liver disease in adults with alpha-1 -antitrypsin deficiency. N Engl J Med. 1972 Dec 21;287(25):1264–1267. doi: 10.1056/NEJM197212212872502. [DOI] [PubMed] [Google Scholar]
- DeLellis R. A., Balogh K., Merk F. B., Chirife A. M. Distinctive hepatic cell globules in adult alpha-1-antitrypsin deficiency. A histochemical, immunohistochemical, and ultrastructural study. Arch Pathol. 1972 Oct;94(4):308–316. [PubMed] [Google Scholar]
- Dekker A., Krause J. R. Hyaline globules in human neoplasms. A report of three autopsy cases. Arch Pathol. 1973 Mar;95(3):178–181. [PubMed] [Google Scholar]
- ERLANGER B. F., KOKOWSKY N., COHEN W. The preparation and properties of two new chromogenic substrates of trypsin. Arch Biochem Biophys. 1961 Nov;95:271–278. doi: 10.1016/0003-9861(61)90145-x. [DOI] [PubMed] [Google Scholar]
- Eriksson S., Hägerstrand I. Cirrhosis and malignant hepatoma in alpha 1-antitrypsin deficiency. Acta Med Scand. 1974 Jun;195(6):451–458. doi: 10.1111/j.0954-6820.1974.tb08170.x. [DOI] [PubMed] [Google Scholar]
- Eriksson S., Larsson C. Purification and partial characterization of pas-positive inclusion bodies from the liver in alpha 1-antitrypsin deficiency. N Engl J Med. 1975 Jan 23;292(4):176–180. doi: 10.1056/NEJM197501232920403. [DOI] [PubMed] [Google Scholar]
- Feldmann G., Bignon J., Chahinian P. The liver in alpha 1-antitrypsin deficiency. Digestion. 1974;10(2):162–174. doi: 10.1159/000197535. [DOI] [PubMed] [Google Scholar]
- Goetz I. E., Weinstein C., Roberts E. Effects of protease inhibitors on growth of hamster tumor cells in culture. Cancer Res. 1972 Nov;32(11):2469–2474. [PubMed] [Google Scholar]
- Lieberman J. Emphysema, cirrhosis, and hepatoma with alpha-1 antitrypsin deficiency. Ann Intern Med. 1974 Dec;81(6):850–852. doi: 10.7326/0003-4819-81-6-850. [DOI] [PubMed] [Google Scholar]
- Lieberman J., Silton R. M., Agliozzo C. M., McMahon J. Hepatocellular carcinoma and intermediate alpha1-antitrypsin deficiency (MZ phenotype). Am J Clin Pathol. 1975 Sep;64(3):304–310. doi: 10.1093/ajcp/64.3.304. [DOI] [PubMed] [Google Scholar]
- Norkin S. A., Campagna-Pinto D. Cytoplasmic hyaline inclusions in hepatoma. Histochemical study. Arch Pathol. 1968 Jul;86(1):25–32. [PubMed] [Google Scholar]
- O'Neill F. J. Limitation of nuclear division by protease inhibitors in cytochalasin-B-treated tumor cells. J Natl Cancer Inst. 1974 Mar;52(3):653–657. doi: 10.1093/jnci/52.3.653. [DOI] [PubMed] [Google Scholar]
- Palmer P. E., Wolfe H. J. Alpha-antitrypsin deposition in primary hepatic carcinomas. Arch Pathol Lab Med. 1976 May;100(5):232–236. [PubMed] [Google Scholar]
- Rawlings W., Jr, Moss J., Cooper H. S., Hamilton S. R. Hepatocellular carcinoma and partial deficiency of alpha-1 antitrypsin (MZ). Ann Intern Med. 1974 Dec;81(6):771–773. doi: 10.7326/0003-4819-81-6-771. [DOI] [PubMed] [Google Scholar]
- Sharp H. L. The current status of alpha-1-antityrpsin, a protease inhibitor, in gastrointestinal disease. Gastroenterology. 1976 Apr;70(4):611–621. [PubMed] [Google Scholar]
- Shulman G. Accuracy and precision in measurement of human serum immunoglobulins G, A and M. S Afr J Med Sci. 1973 Dec;38(3):61–68. [PubMed] [Google Scholar]
- Zwi S., Hurwitz S. S., Cohen C., Prinsloo I., Kagan E. Alpha1-antitrypsin deficiency--an association with hepatic malignancy. S Afr Med J. 1975 Oct 25;49(45):1887–1890. [PubMed] [Google Scholar]